Note: This study is currently only recruiting patients in the hospital.

If you are interested in being notified if this study begins recruiting from the general population, please use the 'I Am Interested' button below.

Study of TPN-101 in Patients with Progressive Supranuclear Palsy (PSP)

The main purpose of this study is to investigate the safety and tolerability (whether side effects can be handled by a patient) of TPN-101 compared to a placebo for the treatment of PSP.

Massachusetts General Hospital Progressive Supranuclear Palsy Neurologic Diseases

Top

Language 1

Language 2

Language 3

Privacy on this site

We collect and process your data on this site to better understand how it is used. You can give your consent to all or selected purposes, or you can decline them all. For more information, see our privacy policy.

Analytics

AnalyticsWe'll collect information about your visit to our site. It helps us understand how the site is used – what's working, what might be broken and what we should improve.

For Researchers

For Admins

Note: This study is currently only recruiting patients in the hospital.

Study of TPN-101 in Patients with Progressive Supranuclear Palsy (PSP)